Search Results - "Vlodavsky, I."

Refine Results
  1. 1

    Heparanase enhances myeloma progression via CXCL10 downregulation by Barash, U, Zohar, Y, Wildbaum, G, Beider, K, Nagler, A, Karin, N, Ilan, N, Vlodavsky, I

    Published in Leukemia (01-11-2014)
    “…In order to explore the mechanism(s) underlying the pro-tumorigenic capacity of heparanase, we established an inducible Tet-on system. Heparanase expression…”
    Get full text
    Journal Article
  2. 2

    Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models by Cassinelli, G., Lanzi, C., Tortoreto, M., Cominetti, D., Petrangolini, G., Favini, E., Zaffaroni, N., Pisano, C., Penco, S., Vlodavsky, I., Zunino, F.

    Published in Biochemical pharmacology (15-05-2013)
    “…The activity of heparanase is responsible for heparan sulfate cleavage, thus resulting in the release of heparan sulfate-bound growth factors. Since heparanase…”
    Get full text
    Journal Article
  3. 3

    Tumor suppressor p53 regulates heparanase gene expression by Baraz, L, Haupt, Y, Elkin, M, Peretz, T, Vlodavsky, I

    Published in Oncogene (29-06-2006)
    “…Mammalian heparanase degrades heparan sulfate, the most prominent polysaccharide of the extracellular matrix. Causal involvement of heparanase in tumor…”
    Get full text
    Journal Article
  4. 4

    Increased expression of heparanase in overt diabetic nephropathy by van den Hoven, M.J., Rops, A.L., Bakker, M.A., Aten, J., Rutjes, N., Roestenberg, P., Goldschmeding, R., Zcharia, E., Vlodavsky, I., van der Vlag, J., Berden, J.H.

    Published in Kidney international (01-12-2006)
    “…In overt diabetic nephropathy (DNP), an increase in the permeability of the glomerular basement membrane (GBM) has been associated with a loss of negatively…”
    Get full text
    Journal Article
  5. 5

    Heparanase is expressed in adult human osteoarthritic cartilage and drives catabolic responses in primary chondrocytes by Gibor, G., Ilan, N., Journo, S., Sharabi, A., Dreyer, J., Gertel, S., Singh, P., Menachem, A., Snir, N., Elkayam, O., Vlodavsky, I., Arad, U.

    Published in Osteoarthritis and cartilage (01-08-2018)
    “…The chondrocytes' pericellular matrix acts as a mechanosensor by sequestering growth factors that are bound to heparan sulfate (HS) proteoglycans. Heparanase…”
    Get full text
    Journal Article
  6. 6

    Heparanase induces tissue factor expression in vascular endothelial and cancer cells by NADIR, Y., BRENNER, B., ZETSER, A., ILAN, N., SHAFAT, I., ZCHARIA, E., GOLDSHMIDT, O., VLODAVSKY, I.

    Published in Journal of thrombosis and haemostasis (01-11-2006)
    “…Background: Over‐expression of tissue factor (TF) and activation of the coagulation system are common in cancer patients. Heparanase is an…”
    Get full text
    Journal Article
  7. 7

    Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients by Nadir, Y, Sarig, G, Axelman, E, Meir, A, Wollner, M, Shafat, I, Hoffman, R, Brenner, B, Vlodavsky, I, Haim, N

    Published in Thrombosis research (01-09-2014)
    “…Abstract Background Heparanase is implicated in angiogenesis and tumor progression. We had earlier demonstrated that heparanase may also affect the hemostatic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Heparanase in glomerular diseases by van den Hoven, M.J., Rops, A.L., Vlodavsky, I., Levidiotis, V., Berden, J.H., van der Vlag, J.

    Published in Kidney international (01-09-2007)
    “…Heparanase is an endo-β(1–4)-D-glucuronidase that degrades heparan sulfate (HS) polysaccharide side chains. The role of heparanase in metastasis, angiogenesis,…”
    Get full text
    Journal Article
  10. 10

    Transgenic over-expression of mammalian heparanase delays prion disease onset and progression by Kovalchuk Ben-Zaken, O., Nissan, I., Tzaban, S., Taraboulos, A., Zcharia, E., Matzger, S., Shafat, I., Vlodavsky, I., Tal, Y.

    “…Cellular heparan sulfate (HS) has a dual role in scrapie pathogenesis; it is required for PrPSc (scrapie prion protein) formation and facilitates infection of…”
    Get full text
    Journal Article
  11. 11

    Heparanase as mediator of angiogenesis: mode of action by Elkin, Michael, Ilan, Neta, Ishai-Michaeli, Rivka, Friedmann, Yael, Papo, Orit, Pecker, Iris, Vlodavsky, Israel

    Published in The FASEB journal (01-07-2001)
    “…ABSTRACT Extracellular matrix (ECM) and basement membranes (BMs) present a physical barrier that requires enzymatic degradation during endothelial cell (EC)…”
    Get full text
    Journal Article
  12. 12

    Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies by OSTROVSKY, O, KOROSTISHEVSKY, M, LEVITE, I, LEIBA, M, GALSKI, H, VLODAVSKY, I, NAGLER, A

    Published in Leukemia (01-11-2007)
    “…Heparanase, endo-beta-D-glucuronidase, degrades heparan sulfate glycosaminoglycans - the principal polysaccharide of the basement membrane and extracellular…”
    Get full text
    Journal Article
  13. 13

    Halofuginone inhibits NF-κB and p38 MAPK in activated T cells by Leiba, M., Cahalon, L., Shimoni, A., Lider, O., Zanin‐Zhorov, A., Hecht, I., Sela, U., Vlodavsky, I., Nagler, A.

    Published in Journal of leukocyte biology (01-08-2006)
    “…Halofuginone, a low molecular weight plant alkaloid, inhibits collagen α1 (I) gene expression in several animal models and in patients with fibrotic disease,…”
    Get full text
    Journal Article
  14. 14

    Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors by Hunter, K E, Palermo, C, Kester, J C, Simpson, K, Li, J-P, Tang, L H, Klimstra, D S, Vlodavsky, I, Joyce, J A

    Published in Oncogene (03-04-2014)
    “…Heparan sulfate proteoglycans are an important and abundant component of the extracellular matrix, which undergo substantial remodeling throughout…”
    Get full text
    Journal Article
  15. 15

    Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria by van den Hoven, M.J., Wijnhoven, T.J., Li, J.-P., Zcharia, E., Dijkman, H.B., Wismans, R.G., Rops, A.L., Lensen, J.F., van den Heuvel, L.P., van Kuppevelt, T.H., Vlodavsky, I., Berden, J.H.M., van der Vlag, J.

    Published in Kidney international (01-02-2008)
    “…Heparan sulfate in the glomerular basement membrane has been considered crucial for charge-selective filtration. In many proteinuric diseases, increased…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Heparanase expression in periapical granulomas and radicular cysts by Elad, S., Sherman, Y., Palmon, A., Vlodavsky, I., Or, R.

    Published in Odontology (2013)
    “…Heparanase is an endo-β- d -glucuronidase enzyme which degrades heparan sulfate glycosaminoglycan side chains of proteoglycans in the extracellular matrix and…”
    Get full text
    Journal Article
  18. 18

    Matrix Metalloproteinase 2 Releases Active Soluble Ectodomain of Fibroblast Growth Factor Receptor 1 by Levi, Ehud, Fridman, Rafael, Miao, Hua-Quan, Ma, Yong-Sheng, Yayon, Avner, Vlodavsky, Israel

    “…Recent studies have demonstrated the existence of a soluble fibroblast growth factor (FGF) receptor type 1 (FGFR1) extracellular domain in the circulation and…”
    Get full text
    Journal Article
  19. 19

    Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival by Bar-Sela, G, Kaplan-Cohen, V, Ilan, N, Vlodavsky, I, Ben-Izhak, O

    Published in Histopathology (01-08-2006)
    “…Aim : To determine the expression and prognostic significance of heparanase in nasopharyngeal carcinoma (NPC). Methods : Immunohistochemistry was performed on…”
    Get full text
    Journal Article
  20. 20